Latest filing published 06 Mar 2026 for AbbVie Inc., €313k. Read the official filing
No signal scores available.
This profile gathers the share dealings of Demetris D. Crum in AbbVie Inc. We count 2 filings; the first trade dates from 18 February 2026 and the latest from 27 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 6 March 2026, reports a share grant of €313k in AbbVie Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations